Paul D. Rubin - 17 Feb 2026 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role: Chief Medical Officer
Signature: /s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol: BIOA
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 16:42:42 UTC
Previous filing: 03 Feb 2026
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
RUBIN PAUL D	Chief Medical Officer	C/O BIOAGE LABS, INC., 5885 HOLLIS STREET, SUITE 370, EMERYVILLE	/s/ Dov A. Goldstein as attorney-in-fact	19 Feb 2026	0001210905

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOA	Stock Option (Right to Buy)	Award	$0	+110,000		$0.000000	110,000	17 Feb 2026	Common Stock	110,000	$19.63	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.